Drug intelligence / Profile preview

yinhuang oral liquid

Development stage: Unknown
Lead developer: Hunan Jiudian Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Yinhuang Oral Liquid is a Traditional Chinese Medicine (TCM) formulation developed and manufactured by Hunan Jiudian Pharmaceutical. It is composed of extracts from *Flos Lonicerae* (honeysuckle) and *Radix Scutellariae* (*Scutellaria baicalensis*), containing key bioactive compounds such as chlorogenic acid and baicalin. The drug is indicated for the treatment of upper respiratory tract infections and pharyngitis, utilizing its anti-inflammatory and antimicrobial properties to alleviate symptoms. It is administered as an oral liquid and is a widely recognized preparation in the Chinese pharmaceutical market for respiratory ailments.

Brand names: Yinhuang Oral Liquid
Other names: 银黄口服液Yinhuang Koufuye

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)

Beyond the preview

Go deeper on yinhuang oral liquid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on yinhuang oral liquid.

Explore the full profile